SARMSARM
LGD-3303
SARM
Also known as LGD3303, lgd 3303
Half-life
~6 hours
What is LGD-3303?
Investigational oral SARM with anabolic intent in muscle and bone.
How LGD-3303 works
Selective AR activation in lean tissue while attempting to reduce prostate stimulation versus testosterone.
Benefits & uses
- Lean muscle/strength
- Bone density support (studied)
- Similar to ligandrol
Common uses: Lean mass, strength (experimental).
LGD-3303 dosage
Protokol doesn't recommend doses for prescription or controlled compounds. Any figures below are reference or observational reports — dosing should be set with a qualified clinician.
- Protocol notes
- 10-20mg daily. Less researched than LGD-4033. Dry lean gains, no water retention.
- Commonly reported
- Observational only; limited human dataObservational use reports — not a recommendation.
LGD-3303 half-life
~6 hours (estimated)
LGD-3303 side effects
- HPT suppression
- Lipid changes
- Limited clinical data
- Testosterone suppression
- Lipid shift
- Limited data
Warnings & monitoring
- Limited human data — experimental. Requires bloodwork + medical guidance
- Suppressive — PCT may be needed
- FDA-warned / WADA-banned / gray-market
- Not approved for human use
Commonly stacked with
Track LGD-3303 in Protokol.
Log doses, model half-lives, check interactions, and line it all up against your bloodwork. Free on iPhone and Android.
More SARM
- ACP-105Investigational nonsteroidal SARM studied for anabolic selectivity.
- Andarine (S4)Dry SARM with significant strength and hardening effects. Known for vision…
- Ligandrol (LGD-4033)Potent oral SARM with strong lean-mass and strength effects.
- Ostarine (MK-2866)The mildest and most studied SARM. Selective androgen receptor modulator with…
- S-23High-potency investigational SARM with strong suppressive activity.
- Testolone (RAD-140)High-potency SARM with pronounced strength and lean-mass effects.